Experimental Hematology Group - VHIO

VHIO’s Experimental Hematology Group conducts translational, pre-clinical and clinical research on hematological neoplasms of both lymphoid and myeloid origin. Our research team is composed of hematologists and biological scientists who work closely together to design, conduct and lead our programs.

Tumor Biomarkers Group - VHIO

Hereditary Cancer Genetics Group - VHIO

Models of Cancer Therapies Group - VHIO

CAR T-cell therapy versus allogeneic HSCT for relapsed or

Experimental Hematology Group - VHIO

Dr. Marta Crespo receives grant from the AECC Barcelona

VHIO consolidates its advanced therapy programme to develop new

Experimental Hematology Group - VHIO

Novel liquid biopsy approach shows 30% increased sensitivity in

IDP Pharma starts clinical trials of its first-in-class IDP-121

COVID-19 in adult acute myeloid leukemia patients: a long-term

Daniel Medina (@danimedinabio) / X